imcy-0098
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 23, 2017 (NCT03272269)
Timeline
Indications
Studied for
Mechanism of action
- Insulin receptorAGONIST
INSR agonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068583 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04524949 | Phase 2 | Dec 29, 2020 | ImCyse |
| NCT04190693 | Phase 1 | Feb 14, 2019 | ImCyse |
| NCT03272269 | Phase 1 | Aug 23, 2017 | ImCyse, Institut Cochin |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImCyse | For profit | 3 | 3 | 2 | 2017 |
| Institut Cochin | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1